We're sunsetting PodQuest on 2025-07-28. Thank you for your support!
Export Podcast Subscriptions

Behind the Money

From hostile takeovers to C-suite intrigue, Behind the Money takes you inside the business and finan

Episodes

Total: 269

FTC versus Amazon

2023/10/11

In its latest fight to curb the power of Big Tech, the US Federal Trade Commission has sued Amazon.

When Argentina’s president announced plans to nationalise an oil company in 2012, it was presented a

This week, we’re revisiting an episode from earlier this year. Apple has spent two decades and billi

As the world transitions away from fossil fuels and the electric vehicle market grows, competition t

Subscribe now to the FT's Tech Tonic podcast: Some scientists believe that rapid advances in artific

Critics argue Russia has a playbook for people who become its targets. On the final episode of the R

This week, we have a bonus episode for you, live from the FT Weekend Festival in London. Michela sat

Sergei Leontiev says he was a political victim of the Putin regime. But when we tracked down other p

In 2015, Sergei Leontiev's life's work — a Russian banking business — was taken away from him o

Who is Sergei Leontiev? To the US asylum system, he’s an exiled Russian banker who was persecuted by

The collapse of FTX sent shockwaves through the crypto ecosystem last year. But it gave rival crypto

Share buybacks are a strategy companies use to return excess cash to their shareholders. But recentl

For decades, the global centre for oil trading has been Geneva, Switzerland. But Russia’s war in Ukr

There’s a new club coming to women’s professional football in the United States. Next season will se

Under “normal” circumstances, economists and analysts study a variety of specific indicators to unde

About 30 years ago, an Australian investment company called Macquarie figured out how to turn public

Frances Haugen was just another Silicon Valley tech worker until she decided to speak up about what

This week, we are revisiting an episode from earlier this year about an obscure firm from the United

Illumina, the world’s biggest gene sequencing company, announced plans to buy cancer detection start

For decades, Crispin Odey sat atop the UK’s hedge fund scene. Lauded by many in financial circles as